Preliminary JAMA Study: Tau Fragment eMTBR-tau243 Is Elevated in Advanced CTE in Blood From 11 People

Researchers at Washington University in St. Louis reported a preliminary finding on November 14, 2026, that a tau protein fragment tied to Alzheimer's disease, eMTBR-tau243, might one day help diagnose a different brain disease, chronic traumatic encephalopathy (CTE), in living people. The findings were published in JAMA and presented at a scientific meeting in Japan.
The team had been using autopsy samples to study whether the fragment can track tau tangles when it found a patient with high levels of the biomarker whose records showed advanced CTE rather than Alzheimer's disease. The researchers then tested stored blood from 11 people who had been classified as having CTE. Compared with healthy people, levels of eMTBR-tau243 were higher in those with advanced CTE, said study co-author Chihiro Sato, a WashU assistant professor of neurology, but the biomarker could not reliably identify early-stage CTE.
CTE is linked to concussions and other repeated head blows, and a diagnosis can currently be confirmed only by examining the brain after death. Dr. Rudolph Castellani, a neuropathologist at Northwestern University who was not involved in the research, cautioned that it is a very preliminary finding requiring far larger studies, and Sato also stressed that much more research is needed.
Published by GSM · USA (original Chinese edition)
Photo: 图中是人脑左侧正中矢状面标本特写,本研究正是通过脑组织与血液样本追踪tau蛋白片段。来源:Wikimedia Commons, File:Human brain left midsagitttal view closeup description 2.JPG, John A Beal, PhD, CC BY 2.5。
Rubin Observatory Finds 2 Hidden Objects in Just 7% of Its Sky: Aquarius IV Dwarf Galaxy Lies About 355,000 Light-Years Away2026-11-15
Follow-Up: Jensen Huang Discusses Returning as Nvidia CEO With Confidants as Allies Build "War Room" to Lobby Board and Seek White House Support, FT Reports2026-11-15